BFEC
OCGN icon

Benjamin F. Edwards & Company’s Ocugen OCGN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed – – 2147
2023
Q3 		$0 Hold
1
– – ﹤0.01% 1802
2023
Q2 		$0 Hold
1
– – ﹤0.01% 1820
2023
Q1 		$0 Hold
1
– – ﹤0.01% 1869
2022
Q4 		$0 Hold
1
– – ﹤0.01% 1888
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1884
2022
Q2 		$0 Buy
+1
New +$2 ﹤0.01% 1869

Other funds holding OCGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Benjamin F. Edwards & Company's OCGN Position: Q4 2023 in Review

Benjamin F. Edwards & Company sold out of Ocugen (OCGN) in Q4 2023, closing a stake of 1 share.

Benjamin F. Edwards & Company first reported a position in OCGN in Q2 2022 and held it in 6 quarters. The position peaked at $0 in Q3 2023. 68 funds tracked by Wall St. Rank hold OCGN as of Q4 2023.

  • Benjamin F. Edwards & Company reported no remaining Ocugen position as of Q4 2023 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 1 Ocugen share in Q4 2023.
  • Benjamin F. Edwards & Company first reported a position in Ocugen in Q2 2022 and held it in 6 quarters.
  • Benjamin F. Edwards & Company's Ocugen position peaked at $0 in Q3 2023.
  • 68 funds tracked by Wall St. Rank held Ocugen as of Q4 2023.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2023, filed 6 Feb 2024.